We are 208,450 members in 81 forums discussing 150,017 topics.

Help with Abbreviations
Announcement icon@2x Announcements

TAILORx Results Suggest About 70% of Women With Early-Stage, Hormone-Receptor-Positive, HER2-Negative Disease Can Skip Chemotherapy
June 4, 2018

Results from the TAILORx study show that about 70% of women diagnosed with hormone-receptor-positive, HER2-negative, node-negative breast cancer do not need chemotherapy after surgery. Read more...

All Topics

Welcome to Breastcancer.org

Not Diagnosed but Concerned

Tests, Treatments & Side Effects

Connecting With Others Who Have a Similar Diagnosis

Day-to-Day Matters

Moving On & Finding Inspiration After Breast Cancer

Community Connections

Site News and Announcements

Advocacy and Fund-Raising